SCHEMBL8909629

SCHEMBL8909629

CCOC(=O)C1=C(C)c2c(C)c3c(cc2=N1)-c1cc(O)ccc1N=3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
CA7 P43166 5/20 0.39
CA9 Q16790 5/20 0.39
CA14 Q9ULX7 5/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
GAA P10253 5/20 0.36
CYP3A4 P08684 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
AKR1B1 P15121 1/20 0.35
KMT2A Q03164 4/20 0.34
HPGD P15428 3/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434374 0.90 SMAD3 (0.39) ESR1GAASMN1; SMN2ALDH1A1HTT
SCHEMBL8909809 0.88 TSHR (0.37) GAASMN1; SMN2KMT2AHPGDMEN1
SCHEMBL8911562 0.87 POLB (0.40) GAACYP3A4HPGDALDH1A1HTT
SCHEMBL8912086 0.87 CYP2C9 (0.39) CA12CA1CA2CA7CA9
SCHEMBL1388815 0.86 MAPT (0.44) CA12CA1CA2CA7CA9
SCHEMBL8910230 0.85 GABRA1 (0.38) GAASMN1; SMN2TDP1KMT2AHPGD
SCHEMBL27429806 0.85 MEN1 (0.32) TDP1KMT2AMEN1HSD17B10
SCHEMBL8909498 0.81 TSHR (0.37) GAASMN1; SMN2KMT2AHPGDMEN1
SCHEMBL8150139 0.79 RAB9A (0.33) SMN1; SMN2TDP1KMT2AALDH1A1CYP1A2
SCHEMBL1388445 0.79 CA12 (0.37) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed